Frazier Life Sciences Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Sell |
|
|||||
|
2025
Q1 | $20.4M | Hold |
|
|||||
|
2024
Q4 | $44.2M | Sell |
|
|||||
|
2024
Q3 | $100M | Sell |
|
|||||
|
2024
Q2 | $78.5M | Sell |
|
|||||
|
2024
Q1 | $77.8M | Sell |
|
|||||
|
2023
Q4 | $73.1M | Hold |
|
|||||
|
2023
Q3 | $59.4M | Hold |
|
|||||
|
2023
Q2 | $58.2M | Sell |
|
|||||
|
2023
Q1 | $52.4M | Hold |
|
|||||
|
2022
Q4 | $67M | Sell |
|
|||||
|
2022
Q3 | $37.1M | Sell |
|
|||||
|
2022
Q2 | $38.9M | Sell |
|
|||||
|
2022
Q1 | $55.8M | Buy |
|